Literature DB >> 17235386

Use of treatment algorithms for depression.

Madhukar H Trivedi, Maurizio Fava, Lauren B Marangell, David N Osser, Richard C Shelton.   

Abstract

Depression continues to be a treatment challenge for many physicians-psychiatrists and primary care physicians alike-in part because of the nature of the disorder, but also because of the wide variety of medications and other treatments available, each with a distinct efficacy and safety profile. One way of negotiating treatment decisions is to use treatment guidelines and algorithms. This Commentary, which appears in the September 2006 issue of The Journal of Clinical Psychiatry (2006;67:1458-1465), provides the primary care clinician with insight into the pros and cons of using treatment algorithms to guide the treatment of depression. -Larry Culpepper, M.D.

Entities:  

Year:  2006        PMID: 17235386      PMCID: PMC1764539          DOI: 10.4088/pcc.v08n0506

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  25 in total

1.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 2.  Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder.

Authors:  George I Papakostas
Journal:  Essent Psychopharmacol       Date:  2005

3.  Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment.

Authors:  M E Thase; A D Simons; J McGeary; J F Cahalane; C Hughes; T Harden; E Friedman
Journal:  Am J Psychiatry       Date:  1992-08       Impact factor: 18.112

4.  Two-year effects of quality improvement programs on medication management for depression.

Authors:  J Unützer; L Rubenstein; W J Katon; L Tang; N Duan; I T Lagomasino; K B Wells
Journal:  Arch Gen Psychiatry       Date:  2001-10

5.  A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression.

Authors:  J C Nelson; C M Mazure; M B Bowers; P I Jatlow
Journal:  Arch Gen Psychiatry       Date:  1991-04

6.  Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

Authors:  Lauren B Marangell; A John Rush; Mark S George; Harold A Sackeim; Christopher R Johnson; Mustafa M Husain; Ziad Nahas; Sarah H Lisanby
Journal:  Biol Psychiatry       Date:  2002-02-15       Impact factor: 13.382

7.  Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.

Authors:  Andrew A Nierenberg; George I Papakostas; Timothy Petersen; Heidi D Montoya; John J Worthington; Joyce Tedlow; Jonathan E Alpert; Maurizio Fava
Journal:  J Clin Psychopharmacol       Date:  2003-02       Impact factor: 3.153

8.  Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.

Authors:  J Craig Nelson; Carolyn M Mazure; Peter I Jatlow; Malcolm B Bowers; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2004-02-01       Impact factor: 13.382

9.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

10.  Response to an open trial of a second SSRI in major depression.

Authors:  R T Joffe; A J Levitt; S T Sokolov; L T Young
Journal:  J Clin Psychiatry       Date:  1996-03       Impact factor: 4.384

View more
  4 in total

Review 1.  Digital technology and clinical decision making in depression treatment: Current findings and future opportunities.

Authors:  Kevin A Hallgren; Amy M Bauer; David C Atkins
Journal:  Depress Anxiety       Date:  2017-04-28       Impact factor: 6.505

Review 2.  Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants.

Authors:  Nikhat J Siddiqi; Maria de Lourdes Pereira; Bechan Sharma
Journal:  Mol Neurobiol       Date:  2022-03-29       Impact factor: 5.590

Review 3.  A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression.

Authors:  Jenifer A Murphy; Jerome Sarris; Gerard J Byrne
Journal:  Depress Res Treat       Date:  2017-08-03

Review 4.  Neurobiology of depression: an integrated view of key findings.

Authors:  V Maletic; M Robinson; T Oakes; S Iyengar; S G Ball; J Russell
Journal:  Int J Clin Pract       Date:  2007-10-17       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.